CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 37 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-22 | HEDRICK MARC H Chief Executive Officer | Purchase | +5,000 | $2.10 | $11K | 5,167 |
| 2020-02-14 | Petersen Greg Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2020-02-06 | Sims Andrew John Hugh MacIntyre Chief Financial Officer | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2020-01-09 | van Es-Johansson An Director | Grant or award · Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2018-07-25 | Hawkins Richard J Director | Option exercise · Subscription Rights (Right to Buy) | −10 | 0 | ||
| 2018-07-25 | Hawkins Richard J Director | Option exercise · Series C Preferred Stock | +10 | 35 | ||
| 2018-07-25 | Hawkins Richard J Director | Option exercise · Warrants (Right to Buy) | +10,500 | 10,500 | ||
| 2018-07-25 | HEDRICK MARC H President and CEO | Option exercise · Subscription Rights (Right to Buy) | −35 | 0 | ||
| 2018-07-25 | HEDRICK MARC H President and CEO | Option exercise · Series C Preferred Stock | +35 | 35 | ||
| 2018-07-25 | HEDRICK MARC H President and CEO | Option exercise · Warrants (Right to Buy) | +36,750 | 36,750 | ||
| 2018-07-25 | Girao Tiago VP & Chief Financial Officer | Option exercise · Subscription Rights (Right to Buy) | −1 | 0 | ||
| 2018-07-25 | Girao Tiago VP & Chief Financial Officer | Option exercise · Series C Preferred Stock | +1 | 1 | ||
| 2018-07-25 | Girao Tiago VP & Chief Financial Officer | Option exercise · Warrants (Right to Buy) | +1,050 | 1,050 | ||
| 2018-02-14 | PostFinance AG 10% owner | Sale | −473,831 | $0.34 | $161K | 4,543,086 |
| 2018-02-13 | PostFinance AG 10% owner | Sale | −101,710 | $0.31 | $32K | 5,016,917 |
| 2018-02-12 | PostFinance AG 10% owner | Sale | −185,272 | $0.31 | $58K | 5,118,627 |
| 2018-02-09 | PostFinance AG 10% owner | Sale | −7,552 | $0.34 | $3K | 5,303,899 |
| 2018-02-08 | PostFinance AG 10% owner | Sale | −228,603 | $0.34 | $78K | 5,311,451 |
| 2018-01-11 | Swissquote Bank SA 10% owner | Sale | −20,000 | $0.34 | $7K | 5,380,859 |
| 2018-01-11 | Swissquote Bank SA 10% owner | Sale | −20,000 | $0.34 | $7K | 5,360,859 |
Page 11 of 53 · 1,048 trades